Steadmed Medical Releases New Drawtex® Edema Wrap
Fort Worth, Texas – April 26, 2018 – SteadMed Medical, a leading provider of acute and chronic wound care products, announces it has developed a new wrap with their core Drawtex Hydroconductive Dressing Technology that assists in the management of edema.
Drawtex, a patented wound dressing with LevaFiber™ Technology, provides effective wound bed preparation through three active mechanisms – Capillary, Hydroconductive, and Electrostatic. The combined use of these three mechanisms results in the drawing ability demonstrated to draw off excessive wound exudate, harmful bacteria, deleterious cytokines, and necrotic debris from the wound. SteadMed developed this product, tested its design and performance by working with clinicians and wound centers across the country. By using their feedback and suggestions, SteadMed was able to leverage the benefits of Drawtex Hydroconductive Wound Dressings and deliver innovation to a complementary segment of wound treatment: the management of edema.
Drawtex Edema Wrap is constructed with a similar process used to create Drawtex Hydroconductive Wound Dressing, however, this new construction has increased conformability, breathability, and length. This will allow Drawtex to employ its mechanisms and benefits to the challenge of managing edema associated with high volumes of collective fluid particularly in lower extremities.
SteadMed Medical continues to dedicate its resources toward innovation in the acute and chronic wound care markets both in the United States and across the world. This product is the second of many new innovations coming for the Drawtex family of products.
For additional information, please visit us at www.steadmed.com.
About SteadMed Medical
SteadMed Medical provides comprehensive solutions for institutions and clinicians caring for patients who suffer from wound and skin complications. Providing high quality, innovative products while keeping costs competitive.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.